Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Anal Chem ; 96(24): 9994-10002, 2024 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-38855895

RESUMO

Therapeutic oligonucleotides (ONs) commonly incorporate phosphorothioate (PS) modifications. These introduce chiral centers and generate ON diastereomers. The increasing number of ONs undergoing clinical trials and reaching the market has led to a growing interest to better characterize the ON diastereomer composition, especially for small interfering ribonucleic acids (siRNAs). In this study, and for the first time, we identify higher-order structures as the major cause of ON diastereomer separation in hydrophilic interaction chromatography (HILIC). We have used conformational predictions and melting profiles of several representative full-length ONs to first analyze ON folding and then run mass spectrometry and HILIC to underpin the link between their folding and diastereomer separation. On top, we show how one can either enhance or suppress diastereomer separation depending on chromatographic settings, such as column temperature, pore size, stationary phase, mobile-phase ionic strength, and organic modifier. This work will significantly facilitate future HILIC-based characterization of PS-containing ONs; e.g., enabling monitoring of batch-to-batch diastereomer distributions in full-length siRNAs, a complex task that is now for the first time shown as possible on this delicate class of therapeutic double-stranded ONs.


Assuntos
Interações Hidrofóbicas e Hidrofílicas , Estereoisomerismo , Oligonucleotídeos/química , Oligonucleotídeos/isolamento & purificação , RNA Interferente Pequeno/química , RNA Interferente Pequeno/isolamento & purificação , Conformação de Ácido Nucleico , Cromatografia Líquida/métodos
2.
Science ; 366(6464): 468-475, 2019 10 25.
Artigo em Inglês | MEDLINE | ID: mdl-31601708

RESUMO

The mTORC1 (mechanistic target of rapamycin complex 1) protein kinase regulates growth in response to nutrients and growth factors. Nutrients promote its translocation to the lysosomal surface, where its Raptor subunit interacts with the Rag guanosine triphosphatase (GTPase)-Ragulator complex. Nutrients switch the heterodimeric Rag GTPases among four different nucleotide-binding states, only one of which (RagA/B•GTP-RagC/D•GDP) permits mTORC1 association. We used cryo-electron microscopy to determine the structure of the supercomplex of Raptor with Rag-Ragulator at a resolution of 3.2 angstroms. Our findings indicate that the Raptor α-solenoid directly detects the nucleotide state of RagA while the Raptor "claw" threads between the GTPase domains to detect that of RagC. Mutations that disrupted Rag-Raptor binding inhibited mTORC1 lysosomal localization and signaling. By comparison with a structure of mTORC1 bound to its activator Rheb, we developed a model of active mTORC1 docked on the lysosome.


Assuntos
Lisossomos/química , Alvo Mecanístico do Complexo 1 de Rapamicina/química , Proteínas Monoméricas de Ligação ao GTP/química , Proteína Regulatória Associada a mTOR/química , Microscopia Crioeletrônica , Humanos , Simulação de Acoplamento Molecular , Estrutura Quaternária de Proteína , Transdução de Sinais
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa